Nov. 27 at 12:51 AM
$DHBUF Hi guys!
DHB posted record revenue for FY2024, up 26% YoY, with Dream Water products leading the charge. Expanded U.S. distribution and new launches, like Sleep Gummies and Immunity Shots, have boosted their footprint. With 74% of sales now coming from international markets, the growth story is shifting beyond Canada.
EBITDA is up 68%, free cash flow turned positive, and gross margins are improving, but SG&A costs kept EPS below estimates. With products already in major chains like Walmart, Kroger, and Shoppers Drug Mart, and upcoming catalysts like U.S. expansion for LivRelief, there’s a lot to consider here.
The full report breaks down the numbers and growth strategy in detail. Read it and share your thoughts—can DHB capitalize on its momentum?: https://www.researchfrc.com/content/reports/post/158/posts-record-revenue-eyes-continued-growth